HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) for AK139, a ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

Age-Related Hearing Loss (ARHL) is a prevalent condition affecting a significant portion of the elderly population worldwide. It is characterized by a ...

Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...